Operating cash flow increased 34.7%
Operating cash flow changed +34.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +34.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -31.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -27.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current assets changed -26.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -3612 basis points from the comparable as-filed period.
Research & development changed -31.5% from the comparable as-filed period.
Operating income changed +18.0% from the comparable as-filed period.
Gross margin changed -356 basis points from the comparable as-filed period.
Total assets changed -20.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capex / revenue changed -1373 basis points from the comparable as-filed period.
Stock-based compensation changed -59.6% from the comparable as-filed period.
SBC / revenue changed -4516 basis points from the comparable as-filed period.
Revenue changed -23.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.